Published Scientific Articles
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Concarlo in the News
Webinars & Talks
Beyond Biotech podcast 24: Concarlo Therapeutics
LabOps: Changing Outcomes for Drug-Resistant Patients with Stacy Blain, Founder, and CSO at Concarlo Therapeutics
Opportunity to Join the Fight Against Metastatic Breast Cancer
Concarlo is on a Mission to Rid the World of Metastatic Breast Cancer